Avastin got an accelerated Food and Drug Administration approval for treatment of glioblastoma, but additional research found the drug didn’t extend patients lives.

Avastin got an accelerated Food and Drug Administration approval for treatment of glioblastoma, but additional research found the drug didn’t extend patients lives